FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)
Product details
Registration number: SIN16043P
Classification: Prescription Only
Active ingredients: Benralizumab
Strength: 30 mg / ml
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: R03DX10
HSA approval date: 18 November 2020
Manufacturer(s):
- Catalent Indiana, LLC
- AstraZeneca Pharmaceuticals LP Frederick Manufacturing Center (FMC) (DP intermediate)
- AstraZeneca AB
- AstraZeneca AB
Manufacturing country/countries: UNITED STATES; SWEDEN
What are the HSA registration number and classification for FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16043P
Classification: Prescription Only
What active ingredients and strength are recorded for FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Benralizumab
Strength: 30 mg / ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Catalent Indiana, LLC
- AstraZeneca Pharmaceuticals LP Frederick Manufacturing Center (FMC) (DP intermediate)
- AstraZeneca AB
- AstraZeneca AB
Manufacturing country/countries: UNITED STATES; SWEDEN
Where can I look up FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN) in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16043P or the exact product name FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN). The general register link does not preselect this product.
What are the source dates for this FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN) record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN) record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16043P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)